Search research articles
Contact Us
Filters
Showing results (61-70 of 114) with videos related to
Page
of 12
Sort By:
Cephalalgia : an International Journal of Headache
|
June 12, 2016
OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: Pooled results from the PREEMPT randomized clinical trial program
Richard B Lipton, Noah L Rosen, Jessica Ailani, et al.
The Journal of Headache and Pain
|
July 26, 2019
Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials
Li Shen Loo, Jessica Ailani, Jack Schim, et al.
The Lancet. Neurology
|
August 22, 2020
Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial
Peter J Goadsby, David W Dodick, Jessica Ailani, et al.
Headache
|
January 25, 2022
Does "wearing off" of efficacy occur in galcanezumab-treated patients at the end of the monthly treatment cycle? Post hoc analyses of four phase III randomized trials
Jessica Ailani, Dulanji K Kuruppu, Mallikarjuna Rettiganti, et al.
The Journal of Headache and Pain
|
January 3, 2025
Reduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial
Lauren Powell, Fiona O'Sullivan, Pramoda Jayasinghe, et al.
Headache
|
November 12, 2019
Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies
Holland C Detke, Brian A Millen, Qi Zhang, et al.
Headache
|
September 24, 2019
Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
Richard B Lipton, Susan Hutchinson, Jessica Ailani, et al.
Headache
|
July 3, 2024
Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacks
Richard B Lipton, Jessica Ailani, Kathleen Mullin, et al.
Mayo Clinic Proceedings
|
April 6, 2020
Characterization of Acute Prescription Migraine Medication Use: Results From the CaMEO Study
Susan Hutchinson, Richard B Lipton, Jessica Ailani, et al.
The New England Journal of Medicine
|
August 18, 2021
Atogepant for the Preventive Treatment of Migraine
Jessica Ailani, Richard B Lipton, Peter J Goadsby, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 114) with videos related to
Sort By:
Page
of 12
Cephalalgia : an International Journal of Headache
|
June 12, 2016
OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: Pooled results from the PREEMPT randomized clinical trial program
Richard B Lipton, Noah L Rosen, Jessica Ailani, et al.
The Journal of Headache and Pain
|
July 26, 2019
Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials
Li Shen Loo, Jessica Ailani, Jack Schim, et al.
The Lancet. Neurology
|
August 22, 2020
Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial
Peter J Goadsby, David W Dodick, Jessica Ailani, et al.
Headache
|
January 25, 2022
Does "wearing off" of efficacy occur in galcanezumab-treated patients at the end of the monthly treatment cycle? Post hoc analyses of four phase III randomized trials
Jessica Ailani, Dulanji K Kuruppu, Mallikarjuna Rettiganti, et al.
The Journal of Headache and Pain
|
January 3, 2025
Reduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial
Lauren Powell, Fiona O'Sullivan, Pramoda Jayasinghe, et al.
Headache
|
November 12, 2019
Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies
Holland C Detke, Brian A Millen, Qi Zhang, et al.
Headache
|
September 24, 2019
Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
Richard B Lipton, Susan Hutchinson, Jessica Ailani, et al.
Headache
|
July 3, 2024
Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacks
Richard B Lipton, Jessica Ailani, Kathleen Mullin, et al.
Mayo Clinic Proceedings
|
April 6, 2020
Characterization of Acute Prescription Migraine Medication Use: Results From the CaMEO Study
Susan Hutchinson, Richard B Lipton, Jessica Ailani, et al.
The New England Journal of Medicine
|
August 18, 2021
Atogepant for the Preventive Treatment of Migraine
Jessica Ailani, Richard B Lipton, Peter J Goadsby, et al.
Page
of 12